New and Updated Clinical Influenza Vaccine Trials
-
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
Oct 7, 2021 | 18:00 pmConditions: ESRD; Influenza Vaccine; SeroprotectionIntervention: Biological: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)Sponsors: Mahidol University; Bhumirajanagarindra Kidney Institute, Thailand; Ministry of Health, ThailandActive, not recruiting
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
Nov 3, 2020 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; Influenza; Solid Organ TransplantInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Feinberg School of Medicine, Northwestern University; University of Alabama at Birmingham; University of WashingtonRecruiting
-
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Sep 30, 2020 | 18:00 pmConditions: Influenza; Influenza -Like IllnessIntervention: Biological: Influenza vaccination at different time pointsSponsors: University of Leicester; Sanofi Pasteur, a Sanofi Company; World Health Organization; University of Warwick; University Hospitals, LeicesterRecruiting
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
Aug 28, 2020 | 18:00 pmCondition: InfluenzaIntervention: Drug: Influenza vaccineSponsor: University of Wisconsin, MadisonCompleted
-
Influenza Vaccine in Lung Transplant Patients - Seroprotection
Aug 28, 2020 | 18:00 pmCondition: InfluenzaIntervention: Drug: Influenza vaccineSponsor: University of Wisconsin, MadisonCompleted
-
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Oct 1, 2019 | 18:00 pmConditions: Influenza; Vaccine Virus SheddingIntervention: Biological: Live attenuated influenza vaccineSponsor: Imperial College Healthcare NHS TrustUnknown status
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
Apr 2, 2019 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting
-
Response to Influenza Vaccine During Pregnancy
Mar 25, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood
Mar 21, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: FluMistSponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting
-
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
Nov 7, 2018 | 18:00 pmConditions: Influenza; Influenza-like IllnessInterventions: Biological: Egg based influenza vaccines; Biological: Recombinant influenza vaccines; Biological: Cell-culture based influenza vaccinesSponsors: Henry M. Jackson Foundation for the Advancement of Military Medicine; National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug Administration (FDA); Defense Health Agency Immunization Healthcare Branch; Armed Forces Health Surveillance Branch; Naval Health Research Center; United States Air Force School of Aerospace Medicine; Uniformed Services University of the Health SciencesRecruiting
-
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
Sep 27, 2018 | 18:00 pmCondition: InfluenzaIntervention: Biological: Seasonal influenza vaccineSponsor: Emory UniversitySuspended
-
Influenza Vaccine Responses
Jul 27, 2018 | 18:00 pmCondition: InfluenzaInterventions: Drug: Fluad Vaccine; Drug: Fluzone High-DoseSponsors: Mayo Clinic; National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting
-
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Jun 28, 2018 | 18:00 pmCondition: Human InfluenzaIntervention: Biological: influenza vaccineSponsors: Research Institute for Biological Safety Problems; Asfendiyarov Kazakh National Medical University; Research Institute of Influenza, RussiaCompleted
-
Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Jun 6, 2018 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent Influenza VaccineSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
Jan 5, 2018 | 18:00 pmCondition: InfluenzaInterventions: Biological: Multi-dose Quadrivalent Influenza Vaccine; Biological: Single-dose Quadrivalent Influenza VaccineSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Improved Novel VaccIne CombinaTion InflUenza Study
Oct 3, 2017 | 18:00 pmCondition: InfluenzaInterventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chlorideSponsors: Vaccitech (UK) Limited; University of OxfordTerminated
-
School-located Influenza Vaccination Clinics for Adolescents
May 3, 2017 | 18:00 pmConditions: Childhood Influenza Vaccination; School-located Influenza VaccinationIntervention: Other: School-located Influenza VaccinationSponsors: University of California, Los Angeles; University of Rochester; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Feb 20, 2017 | 18:00 pmCondition: Influenza VaccinesIntervention: Biological: Seasonal Influenza vaccineSponsor: Butantan InstituteCompleted
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Sep 27, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent vaccine, No PreservativeSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
Jun 30, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza VaccineSponsor: Butantan InstituteCompleted
-
Avian Influenza A(H5N1)- Lao People's Democratic Republic
Nov 17, 2020 | 01:00 amThe Ministry of Health in Lao People's Democratic Republic (PDR) reported a human case of infection with an avian influenza A(H5N1) virus. The case is a one-year-old female who developed symptoms of fever, productive cough, difficulty breathing and runny nose on 13 October 2020. She was hospitalized for her illness on 16 October and discharged on 19 October. As part of severe acute respiratory infection (SARI) sentinel surveillance, a specimen was collected on the date of hospitalization and confirmed to be positive for avian influenza A(H5N1) on 28 October by reverse transcription polymerase chain reaction (RT-PCR) at the National Centre for Laboratory and Epidemiology (NCLE). Among the close contacts of the patient, one contact developed fever and cough after the onset of illness in the case. Specimens collected from all household contacts, including the symptomatic contact, were negative for influenza A viruses.
Read more... -
Human infection with avian influenza A(H7N4) virus – China
Feb 22, 2018 | 04:00 amOn 14 February 2018, the National Health and Family Planning Commission (NHFPC) of China notified the World Health Organization (WHO) of one case of human infection with avian influenza A(H7N4) virus. This is the first human case of avian influenza A(H7N4) infection to be reported worldwide.
Read more... -
Influenza (Avian and other zoonotic)
Jan 22, 2018 | 19:00 pmWHO fact sheet on avian influenza: includes key facts, definition, clinical features, antiviral treatment, risk factors for human infection, human pandemic potential, WHO response.
Read more... -
Human infection with avian influenza A(H7N9) virus – China
Oct 26, 2017 | 16:08 pmOn 8 and 15 September 2017, the National Health and Family Planning Commission of China (NHFPC) notified WHO of two additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus in China.
Read more... -
Human infection with avian influenza A(H7N9) virus – China
Sep 13, 2017 | 11:51 amOn 18, 25 August and 4 September 2017, the National Health and Family Planning Commission of China (NHFPC) notified WHO of four additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus in China.
Read more...
